Education
About Us
Working with TipRanks
Follow Us
Kasten (KAST)
OTHER OTC:KAST
KAST Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume1.15K
Average Volume (3M)159.66K
Market Cap
$468.76K
Enterprise ValueN/A
Total Cash (Recent Filing)$728.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.14
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding62,501,000
10 Day Avg. Volume475,640
30 Day Avg. Volume159,658
Financial Highlights & Ratios
PEG Ratio0.59
Price to Book (P/B)0.99
Price to Sales (P/S)0.00
P/FCF Ratio-0.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
KAST FAQ
What was Kasten ’s price range in the past 12 months?
Kasten lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Kasten ’s market cap?
Kasten ’s market cap is $468.76K.
When is Kasten ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Kasten ’s earnings last quarter?
Currently, no data Available
Is Kasten overvalued?
According to Wall Street analysts Kasten ’s price is currently Overvalued.
Does Kasten pay dividends?
Kasten does not currently pay dividends.
What is Kasten ’s EPS estimate?
Kasten ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kasten have?
Kasten has 62,501,000 shares outstanding.
What happened to Kasten ’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Kasten ?
Currently, no hedge funds are holding shares in KAST
Company Description
Kasten
Kasten, Inc., doing business as DAKOTA Life Sciences, operates as a biopharmaceutical company that focuses on the acquisition, development, and commercialization of pharmaceuticals designed to prevent and treat serious conditions arising in hospital and community settings. It principally focuses on delivering solutions to those people who are affected by antimicrobial resistance and who need pharmaceutical products at affordable prices. The company was incorporated in 1986 and is based in Sioux Falls, South Dakota.
Technical Analysis
Silexion Therapeutics
―
CERo Therapeutics Holdings
―
Psyence Biomedical
―
Zoomcar Holdings
―
Klotho Neurosciences
―